Intrathecal immunoglobulin M synthesis is an independent biomarker for higher disease activity and severity in multiple sclerosis

J Oechtering, S Schaedelin, P Benkert… - Annals of …, 2021 - Wiley Online Library
Objective We aimed to determine in relapsing multiple sclerosis (MS) whether intrathecal
synthesis of immunoglobulin (Ig) M and IgG is associated with outcomes reflecting …

Decoding intrathecal immunoglobulins and B cells in the CNS: their synthesis, function, and regulation: Modulation of immune responses mediated by different B cells …

N Negi, BK Das - International Reviews of Immunology, 2020 - Taylor & Francis
The discovery of an active lymphatic system in the meninges (dura mater) has opened up a
wide range of possibilities for the role of CNS immunoglobulins in brain development in …

[HTML][HTML] Decreased intrathecal concentrations of free light chains kappa in multiple sclerosis patients taking very high effective disease-modifying treatment

M Süße, FF Konen, P Schwenkenbecher, K Budde… - Diagnostics, 2022 - mdpi.com
Free light chains kappa (FLCκ) in cerebrospinal fluid (CSF) are a part of the intrathecal
immune response. This observational study was conducted to investigate the effects of …

[HTML][HTML] Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients

R Magliozzi, V Mazziotti, L Montibeller… - Frontiers in Cellular …, 2020 - frontiersin.org
Background Intrathecal immunoglobulin M (IgM) synthesis has been demonstrated in the
early disease stages of multiple sclerosis (MS) as a predictor factor of a worsening disease …

[HTML][HTML] High levels of cerebrospinal fluid kappa free light chains relate to IgM intrathecal synthesis and might have prognostic implications in relapsing multiple …

J Castillo-Villalba, S Gil-Perotín… - Frontiers in …, 2022 - frontiersin.org
Cerebrospinal kappa free light chain (KFLC)-index is a marker of intrathecal
immunoglobulin synthesis that aids in the diagnosis of multiple sclerosis (MS). However …

Intrathecal IgM as a prognostic marker in multiple sclerosis

MT Mailand, JL Frederiksen - Molecular diagnosis & therapy, 2020 - Springer
One of the great challenges related to multiple sclerosis (MS) research is the identification of
markers of prognosis and treatment response. In the last couple of decades, an association …

Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability

R Capuano, I Zubizarreta… - Multiple Sclerosis …, 2021 - journals.sagepub.com
Background: Prognostic markers are needed to guide multiple sclerosis (MS) management
in the context of large availability of disease-modifying drugs (DMDs). Objective: To …

Effects of natalizumab therapy on intrathecal immunoglobulin G production indicate targeting of plasmablasts

M Schlüter, E Oswald, S Winklmeier… - Neurology …, 2021 - AAN Enterprises
Objectives To evaluate the long-term effects of natalizumab (NTZ) on different features of
intrathecal immunoglobulin (Ig) synthesis in patients with multiple sclerosis (MS) and to …

Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series

M Fonderico, T Biagioli, L Lanzilao… - Multiple Sclerosis …, 2021 - journals.sagepub.com
Background: There is emerging evidence that intrathecal IgM synthesis (ITMS) is a risk factor
for conversion to clinically defined multiple sclerosis (CDMS) in clinically isolated syndrome …

Prognostication and contemporary management of clinically isolated syndrome

CM Allen, E Mowry, M Tintore… - Journal of Neurology …, 2021 - jnnp.bmj.com
Clinically isolated syndrome (CIS) patients present with a single attack of inflammatory
demyelination of the central nervous system. Recent advances in multiple sclerosis (MS) …